Edition:
United Kingdom

Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

200.49USD
19 Jun 2019
Change (% chg)

$2.31 (+1.17%)
Prev Close
$198.18
Open
$198.18
Day's High
$200.72
Day's Low
$197.71
Volume
375,767
Avg. Vol
301,817
52-wk High
$200.72
52-wk Low
$144.77

Summary

Name Age Since Current Position

Kevin Lobo

53 2018 Chairman of the Board, Chief Executive Officer

Timothy Scannell

54 2018 President, Chief Operating Officer

Glenn Boehnlein

57 2016 Chief Financial Officer, Vice President

Viju Menon

51 2018 Group President - Global Quality and Business Operations

M. Kathryn Fink

49 2016 Chief Human Resource Officer, Vice President

Bijoy Sagar

50 2018 Chief Digital Technology Officer, Vice President

William Berry

53 2014 Principal Accounting Officer, Vice President, Corporate Controller

Yin Becker

55 2016 Vice President - Communications, Public Affairs and Corporate Marketing

Katherine Owen

48 2007 Vice President - Strategy and Investor Relations

Robert Fletcher

2019 Vice President, Chief Legal Officer

Michael Hutchinson

48 2019 Vice President

Mary Brainerd

64 2017 Independent Director

Srikant Datar

66 2009 Independent Director

Roch Doliveux

63 2010 Independent Director

Louise Francesconi

64 2006 Independent Director

Allan Golston

51 2011 Independent Director

Sherilyn McCoy

60 Independent Director

Andrew Silvernail

48 2013 Independent Director

Ronda Stryker

63 1984 Independent Director

Rajeev Suri

50 Independent Director

Biographies

Name Description

Kevin Lobo

Mr. Kevin A. Lobo is Chairman of the Board, Chief Executive Officer of the Company. He was named Chairman of the Board in July 2014 and has served as President and Chief Executive Officer of the Company since 2012. He joined the Company as a Group President in April 2011. Prior thereto, he held leadership roles over eight years with Johnson & Johnson, including president of Ethicon Endo-Surgery. Mr. Lobo is also a director of Parker-Hannifin Corporation, a manufacturer of motion and control technologies and systems.

Timothy Scannell

Mr. Timothy J. Scannell is President, Chief Operating Officer of the Company effective August 1, 2018. He began his career with Stryker’s Endoscopy business in 1990 where he served in sales and marketing leadership roles. He then took on roles of increased responsibility spanning many of our businesses and has served as a Group President for nearly a decade, most recently overseeing MedSurg & Neurotechnology. Mr. Scannell serves on the Board of Directors for Insulet Corporation.

Glenn Boehnlein

Mr. Glenn S. Boehnlein is Chief Financial Officer, Vice President of the Company. Mr. Glenn joined Stryker in 2003 as the Vice President of Finance and IT for Stryker’s Endoscopy division and has taken on roles of increasing responsibility, including his current role as Group CFO of MSNT, which he assumed in 2011. He has a strong and established track record and will continue to uphold the financial standards and practices that enable Stryker’s growth. Glenn’s career began with achieving a CPA degree and rising to Partner at Arthur Andersen, where he worked with large private and public companies, including private offerings and M&A transaction consulting. He then spent three years with Success TV as the company’s CFO prior to joining Stryker. Glenn received his Bachelors and Masters in Accounting from Mississippi State University.

Viju Menon

Mr. Viju Menon serves as Group President - Global Quality and Business Operations of the Company. Prior to joining Stryker in April 2018, Mr. Menon held various senior supply chain leadership roles with Verizon Communications Inc. for the previous eight years, most recently as the Chief Supply Chain Officer.

M. Kathryn Fink

Bijoy Sagar

Mr. Bijoy S.N. Sagar serves as Chief Digital Technology Officer, Vice President of the Company. Prior to joining Stryker in May 2014, Mr. Sagar served as the Chief Information Officer for Merck Millipore, and before that as Global Head of Information Systems and a member of the divisional board for the chemicals division of Merck KGaA.

William Berry

Yin Becker

Katherine Owen

Ms. Katherine Ann Owen is Vice President - Strategy and Investor Relations of the Company. Prior to joining the Company, She served as a medical technology analyst at Merrill Lynch. Prior to that she held a similar position at Cowen & Co./SG Cowen and had been a corporate lending analyst at State Street Bank.

Robert Fletcher

Michael Hutchinson

Mary Brainerd

Ms. Mary K. Brainerd serves as an Independent Director of the company. Ms. Brainerd is Former President and Chief Executive Officer of HealthPartners, the largest, consumer-governed, nonprofit health care organization in the United States, which she led from 2002 to May 2017. Prior to joining HealthPartners in 1992, she held various executive roles with Blue Cross and Blue Shield of Minnesota from 1984 to 1992. She also serves as a director of Bremer Bank, a privately held regional financial services company. Ms. Brainerd’s extensive experience surrounding both health care delivery and insurance enable her to provide unique and invaluable insight to our Board discussions, particularly in light of the evolving landscape in the health care delivery and payer markets.

Srikant Datar

Dr. Srikant M. Datar, Ph.D., is an Independent Director of the Company. He is a Professor at the Graduate School of Business Administration of Harvard University since 1996. Faculty Chair of the Harvard Innovation Labs and Senior Associate Dean for University Affairs. From 1989 to 1996, he was Edmund W. Littlefield Professor at the Graduate School of Business, Stanford University. Dr. Datar is also a director of Novartis AG, a multinational pharmaceutical and consumer health products company, ICF International, Inc., a management, technology and policy consulting firm, and T-Mobile US, Inc., a provider of wireless voice, messaging and data services.

Roch Doliveux

Dr. Roch Doliveux, DVM, is an Independent Director of the Company, since June 21, 2010. He is a Chairman of the Board, Pierre Fabre SA, a global dermocosmetics and healthcare company. Chairman of GLG Institute, a community of senior executives for experience sharing and learning. Former Chief Executive Officer of UCB, a global biopharmaceutical company, for 10 years. He is also Chairman of the Board of the Vlerick Business School, a top-100 business school in the world based in Belgium and of the Caring Entrepreneurship Fund, a philanthropic organization to help entrepreneurs start their own business in healthcare.

Louise Francesconi

Ms. Louise L. Francesconi is an Independent Director of the Company, since July 26, 2006. She is Former Vice President of Raytheon Company and former President of Raytheon Missile Systems, which she led from 1996 to July 2008. She is Chairman of the Tucson Medical Center Healthcare Board of Trustees and a director of UNS Energy Corporation, a utility that delivers natural gas and electric service.

Allan Golston

Mr. Allan C. Golston is an Independent Director of the Company, since January 1, 2011. He President, United States Program for the Bill & Melinda Gates Foundation since 2006, and Chief Financial and Administrative Officer of the Bill & Melinda Gates Foundation from 2000 to 2006. Mr. Golston is also a director of Harley-Davidson, Inc., a manufacturer of motorcycles and accessories.

Sherilyn McCoy

Ms. Sherilyn S. McCoy is an Independent Director of the Company. She was Former Chief Executive Officer and Director of Avon Products, Inc., a personal care products company, which she led for almost 6 years until she retired on February 4, 2018. She remains an advisor to the Avon CEO and its board until March 31, 2018. Prior to joining Avon, Ms. McCoy had a 30-year career at Johnson & Johnson, where she led a variety of large medical device, pharmaceutical and consumer businesses and rose to the position of Vice Chair. She is also a director of AstraZeneca plc, a global, science-led biopharmaceutical company.

Andrew Silvernail

Mr. Andrew K. Silvernail is an Independent Director of the company. He is Chairman, President and Chief Executive Officer of IDEX Corporation, Chairman since 2012 and President and Chief Executive Officer since 2011, and Vice President, Group Executive from January 2009 to August 2011. Mr. Silvernail is also a trustee for the Manufacturers Alliance for Productivity and Innovation (MAPI).

Ronda Stryker

Ms. Ronda E. Stryker is an Independent Director of Stryker Corp., since 1984. She is also Vice Chair and a director of Greenleaf Trust, a Michigan chartered bank, Vice Chair of Spelman College, a trustee of Kalamazoo College and member of the Harvard Medical School Board of Fellows.

Rajeev Suri

Mr. Rajeev Suri is an Independent Director of the Company. He is President and Chief Executive Officer of Nokia, a leading global technology company, since April 2014. From 2009 to 2014, he was Chief Executive Officer of Nokia Solutions and Networks (previously Nokia Siemens Networks). Much of his nearly 30-year career has been spent in leadership roles at Nokia. He is also a United Nations Broadband Commissioner, a member of the steering committee of the Digital Communications Industry and a member of the stewardship Board of Health and Healthcare System Initiative at the World Economic Forum.